Experimental Drug Shows Promise in Preventing Diabetic Retinopathy Progression

Johns Hopkins researchers find that hypoglycemia-induced HIF accumulation damages the blood-retinal barrier in diabetic mice, with drug 32-134D offering potential for clinical trials.